Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23153

1.

PCSK9 Inhibitors and Cardiovascular Events.

Sabatine MS, Wasserman SM, Stein EA.

N Engl J Med. 2015 Aug 20;373(8):774-5. No abstract available.

PMID:
26295078
2.

PCSK9 Inhibitors and Cardiovascular Events.

Goemann IM, Londero TM, Dora JM.

N Engl J Med. 2015 Aug 20;373(8):773-4. doi: 10.1056/NEJMc1508222#SA2. No abstract available.

PMID:
26287856
3.

PCSK9 Inhibitors and Cardiovascular Events.

Auer J, Berent R, Primus C.

N Engl J Med. 2015 Aug 20;373(8):773. doi: 10.1056/NEJMc1508222#SA1. No abstract available.

PMID:
26287855
4.

PCSK9 Inhibitors and Cardiovascular Events.

Robinson JG, Kastelein JJ.

N Engl J Med. 2015 Aug 20;373(8):774. doi: 10.1056/NEJMc1508222. No abstract available.

5.

Iomitapide (Lojuxta). Use only in homozygous familial hypercholesterolaemia, with caution.

[No authors listed]

Prescrire Int. 2015 Jul;24(162):176-8.

PMID:
26240881
6.

Immune Mediated Myopathy following Long-Term Statin Therapy.

Watad A, Soriano A, Vaknine H, Shoenfeld Y, Amital H.

Isr Med Assoc J. 2015 Feb;17(2):128-9. No abstract available.

7.

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.

Gaudet D, Alexander VJ, Baker BF, Brisson D, Tremblay K, Singleton W, Geary RS, Hughes SG, Viney NJ, Graham MJ, Crooke RM, Witztum JL, Brunzell JD, Kastelein JJ.

N Engl J Med. 2015 Jul 30;373(5):438-47. doi: 10.1056/NEJMoa1400283.

PMID:
26222559
8.

Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?

Zeman M, Vecka M, Perlík F, Hromádka R, Staňková B, Tvrzická E, Žák A.

Med Sci Monit. 2015 Jul 25;21:2156-62. doi: 10.12659/MSM.893619.

10.

[Very long term follow-up after radiofrequency ablation for atrial fibrillation: the Geneva experience].

Tessitore E, Tran VN, Sunthorn H, Burri H, Namdar M, Shah D.

Rev Med Suisse. 2015 May 27;11(476):1180-4. French.

PMID:
26182636
11.

Ketogenic diet in epileptic children: impact on lipoproteins and oxidative stress.

Lima PA, Sampaio LP, Damasceno NR.

Nutr Neurosci. 2015 Jul 15. [Epub ahead of print]

PMID:
26177187
12.

Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.

Pursnani A, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, Hoffmann U.

JAMA. 2015 Jul 14;314(2):134-41. doi: 10.1001/jama.2015.7515.

PMID:
26172893
13.

Cholesterol Lowering in 2015: Still Answering Questions About How and in Whom.

Greenland P, Lauer MS.

JAMA. 2015 Jul 14;314(2):127-8. doi: 10.1001/jama.2015.7434. No abstract available.

PMID:
26172891
14.

[ISRAELI GUIDELINES FOR THE TREATMENT OF HYPERLIPIDEMIA - 2014 UPDATE].

Bitzur R, Rozenman Y, Vinker S, Dikerl D, Shemesh J, Lahad A, Gavishl D, Harats D, KnobLer H; Society for Research, Prevention and Treatment of Atherosclerosis, Israel; Israel Heart Society; Israel Association of Family Physicians; Israel Society of Internal Medicine.

Harefuah. 2015 May;154(5):330-3, 337-8. Hebrew.

PMID:
26168647
15.
16.

Risk factor burden and control at the time of admission in patients with acute myocardial infarction: Results from the NCDR.

Paixao AR, Enriquez JR, Wang TY, Li S, Berry JD, Khera A, Das SR, de Lemos JA, Kontos MC.

Am Heart J. 2015 Jul;170(1):173-9, 179.e1. doi: 10.1016/j.ahj.2015.04.021. Epub 2015 Apr 24.

PMID:
26093879
17.
18.

The effects of atorvastatin on antioxidant/antiinflammatory properties of HDLs in hypercholesterolemics.

Akalin Çiftçi G, Ertorun İ, Akalin A, Alataş İÖ, Musmul A.

Turk J Med Sci. 2015;45(2):345-51.

PMID:
26084126
19.

Hypolipidemic effects of nimesulide and celecoxib in experimentally induced hypercholesterolemia in rabbits.

Ahmed S, Gul S, Zia-ul-Haq M, Riaz M.

Turk J Med Sci. 2015;45(2):277-83.

PMID:
26084115
20.

[Hypercholesterolemia: Monoclonal antibodies safe and effective].

Windler E.

Dtsch Med Wochenschr. 2015 May;140(11):785-6. doi: 10.1055/s-0041-101630. Epub 2015 May 28. German. No abstract available.

PMID:
26080713
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk